Publicaciones en colaboración con investigadores/as de Ruhr University Bochum (11)

2024

  1. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study

    Brain, Vol. 147, Núm. 8, pp. 2652-2667

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Early life exposure to perfluoroalkyl substances (PFAS) and ADHD: A meta-analysis of nine European population-based studies

    Environmental Health Perspectives, Vol. 128, Núm. 5

  2. New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy

    Brain, Vol. 143, Núm. 9, pp. 2696-2708

  3. The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis

    Cells, Vol. 9, Núm. 1

2019

  1. Enhanced Ex Vivo Generation of Erythroid Cells from Human Induced Pluripotent Stem Cells in a Simplified Cell Culture System with Low Cytokine Support

    Stem Cells and Development, Vol. 28, Núm. 23, pp. 1540-1551

2018

  1. Prenatal and postnatal exposure to persistent organic pollutants and attention-deficit and hyperactivity disorder: A pooled analysis of seven European birth cohort studies

    International Journal of Epidemiology, Vol. 47, Núm. 4, pp. 1082-1097

2017

  1. BMP signaling regulates satellite cell-dependent postnatal muscle growth

    Development (Cambridge), Vol. 144, Núm. 15, pp. 2737-2747

2014

  1. Air pollution during pregnancy and childhood cognitive and psychomotor development: Six european birth cohorts

    Epidemiology, Vol. 25, Núm. 5, pp. 636-647

  2. Prenatal exposure to DDE and PCB 153 and respiratory health in early childhood: A meta-analysis

    Epidemiology, Vol. 25, Núm. 4, pp. 544-553

2013

  1. Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk

    Journal of Medical Genetics, Vol. 50, Núm. 3, pp. 140-143